Cellply, a pioneer in deep functional cell analysis, today announced the completion of the largest portion of its latest funding round, securing €7.15 million to date in the largest financing round completed by the company to date.

Round led by Impact Shakers will scale the Spanish startup's physics-based design platform and roll out Duplantis, an AI copilot for live plant operations.

The financing was led by experienced life science investor Thairm Bio and the Scottish National Investment Bank, with participation from new and existing investors.

The Berlin-based company offers a digital safety and companion solution for older adults, addressing a problem that traditional emergency call systems have failed to solve for decades: user acceptance.

Foamlab, a Delft-based startup working to replace fossil-based plastics with high-performance foams made from bacterial cellulose, has raised €3 million in growth capital to support the construction of a pilot plant, scale up production, and speed up the commercialisation of its biobased foam materials.

Exergy3 has raised £10 million in seed funding to scale its proprietary technology addressing three of Europe’s most pressing challenges: industrial decarbonisation, grid balancing and energy security.

Eka VC announced the final close of its second fund at $107 million (£80 million). This milestone cements Eka’s position as the UK’s largest early-stage impact investor focused on the intersection of health, wellbeing, and sustainability.